RECENT PLACEMENT

Occam Places Wildon Farwell as CMO of Dyne

Occam Places Wildon Farwell as CMO of Dyne

Dyne Therapeutics, an Atlas Investment, is a platform biotech developing therapeutics across neuromuscular indications.

In early 2021, Occam recruited Wildon Farwell, MD as the company’s CMO. Previously, Wildon held a lengthy career at Biogen, having most recently served as the company’s Global Medical Head for Neuromuscular Diseases.

‍

Recent Placements

  1. Carolyn Haley as COO at F-Prime Capital
  2. Chau Cheng as VP of Investor Relations & Corporate Communications at Cytomx
  3. Bryan Stuart as CEO of Atavistik
  4. Bimal Shah as CFO of Corium
  5. Bell Zhong as CFO at Neomorph
About Occam Global

Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide.  Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.  Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression.  Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.